Sticon SRL
Sticon reported total assets of 507,688 € at the end of the 2024 financial year (annual accounts filed with the NBB on 16 Oct 2025).
The score of Sticon shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Total assets +83 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sticon's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 16 Oct 2025
- Year ended 31 Dec 2023filed on 07 Oct 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 17 Jun 2022
- Year ended 31 Dec 2020filed on 27 Oct 2021
Sticon's financial analysis
- Solvency-7.4%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sticon
Sticon's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0668.500.244
- VAT number
- BE0668500244
- Peppol
- Registered · 0208:0668500244 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Dec 2016
- Registered office
- 8700 Tielt
- Latest accounts
- 2024 · filed on 16 Oct 2025
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Sticon (SRL) has been based in Tielt since 2016, active in: research and experimental development on other natural sciences and engineering. For 2024, it reports a net profit of 9,847 € and equity of −37,599 €; its revenue is not published. Its solvency stands at -7.4%, below the median of its sector (60.4%).
Companies similar to Sticon
Companies in the same business, of comparable size and area, outside its group.
- Abaxys Therapeutics Research and experimental development on natural sciences and engineering Villers-la-Ville · balance sheet €1.31m
- Spray Ventures Research and experimental development on natural sciences and engineering Deinze · balance sheet 27,331 €
- BiometrIQ Research and experimental development on natural sciences and engineering Kortrijk · balance sheet €1.65m
- Hugin Mugin Research Research and experimental development on natural sciences and engineering Antwerp · balance sheet 567,097 €
- MSI-Dfat EU Research and experimental development on natural sciences and engineering Jodoigne · balance sheet €1.08m
- Calidris Bio Research and experimental development on natural sciences and engineering Antwerp · balance sheet 506,792 €
- Klinifarm Research and experimental development on natural sciences and engineering Hasselt · balance sheet 487,335 €
- Research Link Research and experimental development on natural sciences and engineering Thuin · balance sheet 477,442 €
Frequently asked questions about Sticon
What is the revenue of Sticon?
Sticon files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Sticon?
In Belgium, the VAT number is the company number prefixed with BE: BE0668500244 for Sticon, if the company is VAT-registered. Its company number (CBE) is 0668.500.244.
Where is the registered office of Sticon?
According to the CBE register, the registered office of Sticon is in 8700 Tielt.
What is the equity of Sticon?
At the close of the 2024 financial year, the equity of Sticon amounts to -37,599 €, a solvency of -7.4% of total assets.
Who manages Sticon?
The register lists 1 active mandates at Sticon. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sticon
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →